HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased effectiveness of 0.01% atropine treatment for myopia control during prolonged COVID-19 lockdowns.

Abstract
The COVID-19 pandemic of 2020 and its' accompanied lockdowns impacted the entire globe in ways the world is only beginning to comprehend. In Israel, children age 9-15 had not been in a frontal classroom and been socially restricted from March 2020 till March 2021. Fourteen of these children that had been under myopia control treatment which had been effective prior to the pandemic were included in this retrospective study to learn if their myopia continued to stay under control, or if the unique environmental modifications affected their progression. The results showed that average increase in spherical equivalent refraction and axial length, measured with optical biometer OA-2000 (Tomey GmbH, Nagoya, Japan), during the year of lockdowns was -0.73 ± 0.46D/0.46 ± 0.31 mm respectively, while the average increase in the year prior was -0.33 ± 0.27D/0.24 ± 0.21 mm. Though several articles have indicated the pandemic environment has influenced myopia progression in children, this communication indicates a possible significant impact of the environment on myopia increase even in individuals under effective atropine treatment. These children's' progression suggests practitioners consider and address multiple aspects simultaneously when attempting myopia control.
AuthorsNir Erdinest, Naomi London, Nadav Levinger, Itay Lavy, Eran Pras, Yair Morad
JournalContact lens & anterior eye : the journal of the British Contact Lens Association (Cont Lens Anterior Eye) Vol. 45 Issue 4 Pg. 101475 (08 2022) ISSN: 1476-5411 [Electronic] England
PMID34238687 (Publication Type: Journal Article)
CopyrightCopyright © 2021 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Ophthalmic Solutions
  • Atropine
Topics
  • Adolescent
  • Atropine
  • Axial Length, Eye
  • COVID-19
  • Child
  • Communicable Disease Control
  • Disease Progression
  • Humans
  • Myopia (therapy)
  • Ophthalmic Solutions
  • Pandemics
  • Refraction, Ocular
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: